Role of chest radiography in the diagnosis of allergic bronchopulmonary aspergillosis in adult patients with cystic fibrosis

被引:10
|
作者
Cortese G. [1 ]
Malfitana V. [1 ]
Placido R. [1 ]
Ferrari A. [1 ]
Grosso B. [2 ]
De Rose V. [2 ]
Nespoli P. [3 ]
Fava C. [3 ]
机构
[1] Servizio di Radiologia, Ospedale degli Infermi, I-13900 Biella
[2] Clinica di Malattie dell'Apparato Respiratorio, Università degli Studi di Torino
[3] S.C.D.U. Radiologia Diagnostica, Dipartimento di Scienze Cliniche e Biologiche, Università degli Studi di Torino, I-10043 Orbassano, A.S.O. S. L. Gonzaga
关键词
ABPA; Chest X-ray; Cystic fibrosis in adult patients;
D O I
10.1007/s11547-007-0169-x
中图分类号
学科分类号
摘要
Purpose. This study aimed to verify the usefulness of chest radiography in the diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in adult patients with cystic fibrosis. Materials and methods. Eleven patients (with a total of 14 episodes) affected by ABPA were selected from among subjects attending a Regional Cystic Fibrosis Centre. For each episode, we retrospectively reviewed the baseline chest radiographs obtained before the diagnosis of ABPA, those obtained during the course of ABPA and those obtained during follow-up. Radiographs were assessed for the presence of bronchial wall thickening, bronchiectasis, infiltrates, atelectasis, mucoid impaction, lymphadenopathy, pleural effusion and fluid levels. Radiographic findings that had appeared at the time of ABPA diagnosis and disappeared after treatment were considered related to ABPA and thus useful for a correct diagnosis of the disease. Chest radiograph abnormalities were compared with changes on the respiratory function tests [forced expiratory volume in 1 s (FEV1)] during the different stages of the disease. Results. Radiographic findings at the time of ABPA diagnosis appeared to have deteriorated in 8/14 cases when compared with the baseline films; after treatment, the radiographic findings deteriorated in 6/14 cases and improved in 6/14. The most significant among the radiographic signs considered (infiltrates and mucoid impaction) appeared at the time of ABPA diagnosis in 7/14 and 4/14 cases, respectively, and in some patients, they were also present at baseline and persisted during follow-up. FEV1 values were significantly decreased (>10%) in 9/14 cases at the time of ABPA diagnosis. Conclusions. Our results demonstrate the limited usefulness of chest radiography in the diagnosis of ABPA in patients with cystic fibrosis. The most significant abnormalities are nonspecific and commonly seen on baseline films in cystic fibrosis without ABPA and persist after treatment in most cases. © 2007 Springer-Verlag.
引用
收藏
页码:626 / 636
页数:10
相关论文
共 50 条
  • [1] Role of chest radiography in the diagnosis of allergic bronchopulmonary aspergillosis in adult patients with cystic fibrosis
    Cortese, G.
    Malfitana, V.
    Placido, R.
    Ferrari, A.
    Grosso, B.
    De Rose, V.
    Nespoli, P.
    Fava, C.
    RADIOLOGIA MEDICA, 2007, 112 (05): : 626 - 636
  • [2] Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
    Delgado Pecellin, Isabel
    Quintana Gallego, Esther
    Pedregal Solano, Celeste
    Calero Acuna, Carmen
    MEDICINA CLINICA, 2015, 144 (04): : 190 - 191
  • [3] Allergic bronchopulmonary aspergillosis and cystic fibrosis
    Levy, MB
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 : S579 - S583
  • [4] Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
    Ashkenazi, Moshe
    Sity, Saray
    Sarouk, Ifat
    El Bar Aluma, Bat
    Dagan, Adi
    Bezalel, Yael
    Bentur, Lea
    De Boeck, Kris
    Efrati, Ori
    JOURNAL OF ASTHMA AND ALLERGY, 2018, 11 : 101 - 107
  • [5] Allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF). Clinical importance, diagnosis and treatment
    Paul, KD
    Leupold, W
    BlaschkeHellmessen, R
    Ulbrich, K
    PeterKern, M
    Neumeister, V
    MYCOSES, 1996, 39 : 55 - 58
  • [6] Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients
    Nove-Josserand, Raphaele
    Grard, Soazic
    Auzou, Lila
    Reix, Philippe
    Murris-Espin, Marlene
    Bremont, Francois
    Mammar, Benyebka
    Mely, Laurent
    Hubert, Dominique
    Durieu, Isabelle
    Burgel, Pierre-Regis
    PEDIATRIC PULMONOLOGY, 2017, 52 (02) : 190 - 197
  • [7] Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis
    Sunman, Birce
    Ademhan Tural, Dilber
    Ozsezen, Beste
    Emiralioglu, Nagehan
    Yalcin, Ebru
    Ozcelik, Ugur
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [8] Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
    Emiralioglu, Nagehan
    Dogru, Deniz
    Tugcu, Gokcen Dilsa
    Yalcin, Ebru
    Kiper, Nural
    Ozcelik, Ugur
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (03) : 188 - 193
  • [9] VARIABILITY IN PARAMETERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH CYSTIC-FIBROSIS
    HUTCHESON, PS
    REJENT, AJ
    SLAVIN, RG
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (03) : 390 - 394
  • [10] Allergic bronchopulmonary aspergillosis without asthma or cystic fibrosis
    Kaur, Parminder
    Kumar, Pankaj
    Randev, Shivani
    Guglani, Vishal
    PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, 2020, 40 (03) : 199 - 201